{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 437183410
| IUPAC_name = 2-methyl-3-phenylbutan-2-amine
| image = Pentorex.svg

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 434-43-5
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 22031
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = K97CJK0FXR
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 20703

<!--Chemical data-->
| C=11 | H=17 | N=1 
| molecular_weight = 163.259 g/mol
| smiles            = CC(C1=CC=CC=C1)C(C)(C)N
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C11H17N/c1-9(11(2,3)12)10-7-5-4-6-8-10/h4-9H,12H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = UMWAUEZOGHNSCH-UHFFFAOYSA-N
}}

'''Pentorex''' ('''Modatrop'''), also known as '''phenpentermine''' or '''α,β-dimethylamphetamine''', is a [[stimulant]] drug related to [[phentermine]] which is used as an [[anorectic]] to assist with weight loss.<ref>{{ cite journal |author1=Behrendt, W. A. |author2=Deininger, R. | title = On the Pharmacology of 2-Phenyl-3-methyl-3-aminobutane, a Substance with Anorexic Properties | language = German | journal = Arzneimittelforschung | year = 1963 | volume = 13 | issue = 8 | pages = 711–716 | pmid = 14090434 }}</ref><ref>{{ cite journal |author1=Opitz, K. |author2=Kemper, F. |author3=Loeser, A. | title = Comparative Study of the Anorexigenic Potency of some Appetite Depressants | language = German | journal = Arzneimittelforschung | year = 1965 | volume = 15 | issue = 3 | pages = 278–281 | pmid = 5897218 }}</ref> It also acts as a [[diuretic]].<ref>{{ cite journal | author = Opitz, K. | title = [Natriuretic and Diuretic Effect of Appetite Depressant Amphetamine Derivatives] | language = German | journal = Klinische Wochenschrift | year = 1965 | volume = 43 | issue = 4 | pages = 225–227 | pmid = 14265209 | issn = 0023-2173 | doi = 10.1007/BF02350860 }}</ref> Pentorex was developed by Nordmark in the 1960s.<ref>{{ cite patent | country = GB | status = patent | number = 995063 | title = A Substituted Butylamine and Salts thereof | assign1 = Nordmark | gdate = 1965-06-10 }}</ref>

== References ==
{{Reflist}}

{{Stimulants}}
{{Anorectics}}
{{Monoamine releasing agents}}
{{Phenethylamines}}

[[Category:Substituted amphetamines]]
[[Category:Anorectics]]
[[Category:Norepinephrine-dopamine releasing agents]]


{{nervous-system-drug-stub}}